01873.HK
Viva Biotech Holdings
HKSE · Healthcare · Biotechnology · CN
HKD 1.25
−1.96%Margins
Gross margin
34.6%
EBITDA margin
20.8%
EBIT margin
10.1%
Net margin
9.4%
FCF margin
15.1%
4.5%
Return on equity
2.6%
Return on assets
3.9%
Return on invested capital
0.27x
Asset turnover
HKD 503.7M
Cash from operations
HKD 0.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026